BioSpace News Archive

Baylor Scott & White Research Institute, the research arm of Baylor Scott & White Health; the Translational Genomics Research Institute, part of City of Hope, a nonprofit biomedical research center; and OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, announced a new research study.

RoslinCT and Lykan Bioscience, a leader in Contract Development and Manufacturing for cell therapies, announced the appointment of Michael Mendicino, Ph.D. to its Scientific Advisory Board.

BioLife Solutions, Inc., a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy and the broader biopharma markets, announced that the Company was recently named as one of Seattle Business magazine’s Washington’s Best Companies to Work for.

ATCC to provide biological standards to support research efforts of the Targeted Evaluation of Ionizing Radiation Exposure (TEI-REX) program. MANASSAS, Va.--( BUSINESS WIRE )-- ATCC , the world’s premier biological materials management and standards organization, today announced that it would be supporting Areté , one of the four winning teams awarded a contract from the Intelligence Advanced Research Projects Activity ( IARPA ), the research and development arm of the Office of the D

Twist Bioscience Corporation and Centogene N.V. today announced the launch of three next-generation sequencing (NGS) target enrichment panels to support rare disease and hereditary cancer research and support diagnostics.

Nascent Biotech, Inc. announced today the completion and closure of enrollment for the final cohort of patients involved in the Company’s Phase I trial to evaluate Pritumumab as a treatment for Brain Cancer.

Santhera Pharmaceuticals announces that through a share exchange it will receive the equivalent of CHF 5 million Idorsia shares whichSanthera is free to sell at its own discretion in support of its short-term financial needs.

Dizal announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted the New Drug Application for sunvozertinib for the treatment of advanced NSCLC with EGFR exon20ins mutations after platinum-based chemotherapies.

Calibre Scientific is pleased to announce the acquisition of Dynalab Corp., a Rochester, NY based distributor and manufacturer of laboratory plastics, consumables, equipment, supplies and custom fabricated products serving the scientific, industrial, agricultural, water, pharma and educational markets in the United States.

The EACVI and Surgical Science have joined forces to create a unique TOE online simulator, aiming to evaluate TOE knowledge and performance level among young cardiologists and assess the need for simulation training for this purpose.